AbCellera director Michael R. Hayden reports $570,442 common share purchase
ABCL•Director reports common share purchase
- AbCellera Biologics director Hayden Michael R. Hayden reported a purchase of 53,613 common shares at USD 10.64.
- Indirect holdings tied to the reporting person rose to 1,373,397 common shares.
- A separate indirect position of 118,245 common shares was reported as held by the reporting person’s spouse.
